Mutant Cockayne syndrome group B protein inhibits repair of DNA topoisomerase I-DNA covalent complex

被引:20
作者
Horibata, Katsuyoshi [1 ]
Saijo, Masafumi [1 ]
Bay, Mui N. [1 ]
Lan, Li [2 ]
Kuraoka, Isao [1 ]
Brooks, Philip J. [3 ]
Honma, Masamitsu [4 ]
Nohmi, Takehiko [4 ]
Yasui, Akira [2 ]
Tanaka, Kiyoji [1 ]
机构
[1] Osaka Univ, Human Cell Biol Grp, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome, Aoba Ku, Sendai, Miyagi 9808575, Japan
[3] NIAAA, Mol Neurobiol Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
[4] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan
关键词
UV-SENSITIVE SYNDROME; CSB GENE; XERODERMA-PIGMENTOSUM; CLEAVAGE COMPLEXES; OXIDATIVE STRESS; SYNDROME CELLS; DAMAGE; DEGRADATION; DEFECT; CAMPTOTHECIN;
D O I
10.1111/j.1365-2443.2010.01467.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Two UV-sensitive syndrome patients who have mild photosensitivity without detectable somatic abnormalities lack detectable Cockayne syndrome group B (CSB) protein because of a homozygous null mutation in the CSB gene. In contrast, mutant CSB proteins are produced in CS-B patients with the severe somatic abnormalities of Cockayne syndrome and photosensitivity. It is known that the piggyBac transposable element derived 3 is integrated within the CSB intron 5, and that CSB-piggyBac transposable element derived 3 fusion (CPFP) mRNA is produced by alternative splicing. We found that CPFP or truncated CSB protein derived from CPFP mRNA was stably produced in CS-B patients, and that wild-type CSB, CPFP, and truncated CSB protein interacted with DNA topoisomerase I. We also found that CPFP inhibited repair of a camptothecin-induced topoisomerase I-DNA covalent complex. The inhibition was suppressed by the presence of wild-type CSB, consistent with the autosomal recessive inheritance of Cockayne syndrome. These results suggested that reduced repair of a DNA topoisomerase I-DNA covalent complex because of truncated CSB proteins is involved in the pathogenesis of CS-B.
引用
收藏
页码:101 / 114
页数:14
相关论文
共 36 条
[11]   Transcription-coupled DNA repair: two decades of progress and surprises [J].
Hanawalt, Philip C. ;
Spivak, Graciela .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (12) :958-970
[12]   Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome [J].
Horibata, K ;
Iwamoto, Y ;
Kuraoka, I ;
Jaspers, NGJ ;
Kurimasa, A ;
Oshimura, M ;
Ichihashi, M ;
Tanaka, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (43) :15410-15415
[13]  
ITOH T, 1995, AM J HUM GENET, V56, P1267
[14]   Deletion of 5′ sequences of the CSB gene provides insight into the pathophysiology of Cockayne syndrome [J].
Laugel, Vincent ;
Dalloz, Cecile ;
Stary, Anne ;
Cormier-Daire, Valerie ;
Desguerre, Isabelle ;
Renouil, Michel ;
Fourmaintraux, Alain ;
Velez-Cruz, Renier ;
Egly, Jean-Marc ;
Sarasin, Alain ;
Dollfus, Helene .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (03) :320-327
[15]   Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells [J].
Lejeune, F ;
Maquat, LE .
CURRENT OPINION IN CELL BIOLOGY, 2005, 17 (03) :309-315
[16]   Human DNA topoisomerase I: relaxation, roles, and damage control [J].
Leppard, JB ;
Champoux, JJ .
CHROMOSOMA, 2005, 114 (02) :75-85
[17]  
MAYNE LV, 1982, CANCER RES, V42, P1473
[18]   Manitoba aboriginal kindred with original cerebro-oculo-facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene [J].
Meira, LB ;
Graham, JM ;
Greenberg, CR ;
Busch, DB ;
Doughty, ATB ;
Ziffer, DW ;
Coleman, DM ;
Savre-Train, I ;
Friedberg, EC .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (04) :1221-1228
[19]   Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes [J].
Miao, Ze-Hong ;
Agama, Keli ;
Sordet, Olivier ;
Povirk, Lawrence ;
Kohn, Kurt W. ;
Pommier, Yves .
DNA REPAIR, 2006, 5 (12) :1489-1494
[20]   Cockayne syndrome without typical clinical manifestations including neurologic abnormalities [J].
Miyauchi-Hashimoto, H ;
Akaeda, T ;
Maihara, T ;
Ikenaga, M ;
Horio, T .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (04) :565-570